Evidence map›Paper›PMID 32558186›Full record

ArticleEMBO reports2020

SHLD2 promotes class switch recombination by preventing inactivating deletions within the Igh locus.

Alexanda K Ling, Meagan Munro, Natasha Chaudhary, Conglei Li, Maribel Berru, Brendan Wu, Daniel Durocher, Alberto Martin

Open access · greenAbstract read
In one paragraph

Article in EMBO reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 31 citations in OpenAlex.

  1. Science advances · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. DNA Damage Response and Repair in Adaptive Immunity.Frontiers in cell and developmental biology · 2022
    Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. The flexible and iterative steps within the NHEJ pathway.Progress in biophysics and molecular biology
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Alexanda K LingDepartment of Immunology, University of Toronto, Toronto, ON, Canada.
Meagan MunroLunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, ON, Canada.
Natasha ChaudharyLunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, ON, Canada.
Conglei LiDepartment of Immunology, University of Toronto, Toronto, ON, Canada.
Maribel BerruDepartment of Immunology, University of Toronto, Toronto, ON, Canada.
Brendan WuDepartment of Immunology, University of Toronto, Toronto, ON, Canada.ORCID 0000-0002-2892-864X
Daniel DurocherLunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, ON, Canada.ORCID 0000-0003-3863-8635
Alberto MartinDepartment of Immunology, University of Toronto, Toronto, ON, Canada.ORCID 0000-0002-0795-0418
University of Toronto · CAMount Sinai Hospital · CA

Funding

CIHR FDN143343CIHR PJT-153307
6 · The paper itself

Abstract

The newly identified shieldin complex, composed of SHLD1, SHLD2, SHLD3, and REV7, lies downstream of 53BP1 and acts to inhibit DNA resection and promote NHEJ. Here, we show that Shld2

Indexed as

DNA Breaks, Double-StrandedImmunoglobulin Class SwitchingAnimalsMiceB cellBRCA1class switch recombinationshieldinShld2−/− mouse

Identifiers

PMID32558186
PMCPMC7403657
OpenAlexW3035879071

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.